FDA accepts IND for cancer mAbs
Morphotek has announced the Food and Drug Administration (FDA) has accepted its New Drug Application for a humanised monoclonal antibody, intended for the treatment of advanced ovarian cancer.
Archives for March 29, 2005
Cleanroom in place for nanotech cancer drug
UK company Atomising Systems Ltd has completed construction of a cleanroom facility at its plant in Sheffeld, UK, that will be used to produce a delivery vehicle used in Brachysil, a candidate drug for liver cancer.
Elsevier builds electronic notebook for lab
In response to industry and customer demand, Elsevier is to build an electronic notebook (ELN) designed for the life sciences industry and which will significantly reduce cycle time in biopharmaceutical R&D, writes Wai Lang Chu.
Process speeds up plasmid purification
Boehringer Ingelheim and Slovenian company BIA Separations have collaborated on a new separation and purification system that should improve the production of plasmid DNA.
Europe faces cancer 'brain drain'
Europe is set to fall further behind in the development of novel anti-cancer agents unless it doubles the amount spent on academic clinical trials. New and more effective non-drug interventions and prognostic markers depend on these trials for their...
SurModics eyeing drug delivery polymers
US company SurModics is evaluating a biodegradeable polymer technology, developed at Rutgers University, that could improve the delivery of drugs into the eye.
Elan break-up under discussion?
Ireland's largest home grown pharmaceutical company, Elan Holdings, could be split up into two separate units, one focussing on biotechnology and the other on manufacturing and drug delivery, according to UK news reports.
Roche's patent expiration opens US market
Swiss pharmaceutical firm, Hoffman-La Roche has announced its core PCR patents have expired in an event that is expected to save laboratories, which rely on this technology, millions of dollars a year in royalties. It is also expected to generate a...
Jasco launches V-7000 series spectrophotometers
Jasco unveils its latest series of spectrophotometers, which offers improved spectral resolution, resolving peaks of less than 0.5 nm. The advance in clarity makes this technology suitable for applications from 175-3300nm.